Immuno Vaccine Inc (IMV)

[John-Knee]

EPS for ImmunoVaccine Inc. (IMV) Expected At $-0.02

Analysts expect ImmunoVaccine Inc. (TSX:IMV) to report $-0.02 EPS on May, 9.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.02 EPS. After having $-0.03 EPS previously, ImmunoVaccine Inc.’s analysts see -33.33% EPS growth. It is down 109.09% since September 27, 2016 and is uptrending. It has outperformed by 98.53% the S&P500.